Cargando…

A tool for evaluating heterogeneity in avidity of polyclonal antibodies

Diversity in specificity of polyclonal antibody (pAb) responses is extensively investigated in vaccine efficacy or immunological evaluations, but the heterogeneity in antibody avidity is rarely probed as convenient tools are lacking. Here we have developed a polyclonal antibodies avidity resolution...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Kan, Dodds, Michael, Spreng, Rachel L., Abraha, Milite, Huntwork, Richard H. C., Dahora, Lindsay C., Nyanhete, Tinashe, Dutta, Sheetij, Wille-Reece, Ulrike, Jongert, Erik, Ewer, Katie J., Hill, Adrian V. S., Jin, Celina, Hill, Jennifer, Pollard, Andrew J., Munir Alam, S., Tomaras, Georgia D., Dennison, S. Moses
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978818/
https://www.ncbi.nlm.nih.gov/pubmed/36875126
http://dx.doi.org/10.3389/fimmu.2023.1049673
_version_ 1784899602199085056
author Li, Kan
Dodds, Michael
Spreng, Rachel L.
Abraha, Milite
Huntwork, Richard H. C.
Dahora, Lindsay C.
Nyanhete, Tinashe
Dutta, Sheetij
Wille-Reece, Ulrike
Jongert, Erik
Ewer, Katie J.
Hill, Adrian V. S.
Jin, Celina
Hill, Jennifer
Pollard, Andrew J.
Munir Alam, S.
Tomaras, Georgia D.
Dennison, S. Moses
author_facet Li, Kan
Dodds, Michael
Spreng, Rachel L.
Abraha, Milite
Huntwork, Richard H. C.
Dahora, Lindsay C.
Nyanhete, Tinashe
Dutta, Sheetij
Wille-Reece, Ulrike
Jongert, Erik
Ewer, Katie J.
Hill, Adrian V. S.
Jin, Celina
Hill, Jennifer
Pollard, Andrew J.
Munir Alam, S.
Tomaras, Georgia D.
Dennison, S. Moses
author_sort Li, Kan
collection PubMed
description Diversity in specificity of polyclonal antibody (pAb) responses is extensively investigated in vaccine efficacy or immunological evaluations, but the heterogeneity in antibody avidity is rarely probed as convenient tools are lacking. Here we have developed a polyclonal antibodies avidity resolution tool (PAART) for use with label-free techniques, such as surface plasmon resonance and biolayer interferometry, that can monitor pAb-antigen interactions in real time to measure dissociation rate constant (k(d) ) for defining avidity. PAART utilizes a sum of exponentials model to fit the dissociation time-courses of pAb-antigens interactions and resolve multiple k(d) contributing to the overall dissociation. Each k(d) value of pAb dissociation resolved by PAART corresponds to a group of antibodies with similar avidity. PAART is designed to identify the minimum number of exponentials required to explain the dissociation course and guards against overfitting of data by parsimony selection of best model using Akaike information criterion. Validation of PAART was performed using binary mixtures of monoclonal antibodies of same specificity but differing in k(d) of the interaction with their epitope. We applied PAART to examine the heterogeneity in avidities of pAb from malaria and typhoid vaccinees, and individuals living with HIV-1 that naturally control the viral load. In many cases, two to three k(d) were dissected indicating the heterogeneity of pAb avidities. We showcase examples of affinity maturation of vaccine induced pAb responses at component level and enhanced resolution of heterogeneity in avidity when antigen-binding fragments (Fab) are used instead of polyclonal IgG antibodies. The utility of PAART can be manifold in examining circulating pAb characteristics and could inform vaccine strategies aimed to guide the host humoral immune response.
format Online
Article
Text
id pubmed-9978818
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99788182023-03-03 A tool for evaluating heterogeneity in avidity of polyclonal antibodies Li, Kan Dodds, Michael Spreng, Rachel L. Abraha, Milite Huntwork, Richard H. C. Dahora, Lindsay C. Nyanhete, Tinashe Dutta, Sheetij Wille-Reece, Ulrike Jongert, Erik Ewer, Katie J. Hill, Adrian V. S. Jin, Celina Hill, Jennifer Pollard, Andrew J. Munir Alam, S. Tomaras, Georgia D. Dennison, S. Moses Front Immunol Immunology Diversity in specificity of polyclonal antibody (pAb) responses is extensively investigated in vaccine efficacy or immunological evaluations, but the heterogeneity in antibody avidity is rarely probed as convenient tools are lacking. Here we have developed a polyclonal antibodies avidity resolution tool (PAART) for use with label-free techniques, such as surface plasmon resonance and biolayer interferometry, that can monitor pAb-antigen interactions in real time to measure dissociation rate constant (k(d) ) for defining avidity. PAART utilizes a sum of exponentials model to fit the dissociation time-courses of pAb-antigens interactions and resolve multiple k(d) contributing to the overall dissociation. Each k(d) value of pAb dissociation resolved by PAART corresponds to a group of antibodies with similar avidity. PAART is designed to identify the minimum number of exponentials required to explain the dissociation course and guards against overfitting of data by parsimony selection of best model using Akaike information criterion. Validation of PAART was performed using binary mixtures of monoclonal antibodies of same specificity but differing in k(d) of the interaction with their epitope. We applied PAART to examine the heterogeneity in avidities of pAb from malaria and typhoid vaccinees, and individuals living with HIV-1 that naturally control the viral load. In many cases, two to three k(d) were dissected indicating the heterogeneity of pAb avidities. We showcase examples of affinity maturation of vaccine induced pAb responses at component level and enhanced resolution of heterogeneity in avidity when antigen-binding fragments (Fab) are used instead of polyclonal IgG antibodies. The utility of PAART can be manifold in examining circulating pAb characteristics and could inform vaccine strategies aimed to guide the host humoral immune response. Frontiers Media S.A. 2023-02-16 /pmc/articles/PMC9978818/ /pubmed/36875126 http://dx.doi.org/10.3389/fimmu.2023.1049673 Text en Copyright © 2023 Li, Dodds, Spreng, Abraha, Huntwork, Dahora, Nyanhete, Dutta, Wille-Reece, Jongert, Ewer, Hill, Jin, Hill, Pollard, Munir Alam, Tomaras and Dennison https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Li, Kan
Dodds, Michael
Spreng, Rachel L.
Abraha, Milite
Huntwork, Richard H. C.
Dahora, Lindsay C.
Nyanhete, Tinashe
Dutta, Sheetij
Wille-Reece, Ulrike
Jongert, Erik
Ewer, Katie J.
Hill, Adrian V. S.
Jin, Celina
Hill, Jennifer
Pollard, Andrew J.
Munir Alam, S.
Tomaras, Georgia D.
Dennison, S. Moses
A tool for evaluating heterogeneity in avidity of polyclonal antibodies
title A tool for evaluating heterogeneity in avidity of polyclonal antibodies
title_full A tool for evaluating heterogeneity in avidity of polyclonal antibodies
title_fullStr A tool for evaluating heterogeneity in avidity of polyclonal antibodies
title_full_unstemmed A tool for evaluating heterogeneity in avidity of polyclonal antibodies
title_short A tool for evaluating heterogeneity in avidity of polyclonal antibodies
title_sort tool for evaluating heterogeneity in avidity of polyclonal antibodies
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978818/
https://www.ncbi.nlm.nih.gov/pubmed/36875126
http://dx.doi.org/10.3389/fimmu.2023.1049673
work_keys_str_mv AT likan atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT doddsmichael atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT sprengrachell atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT abrahamilite atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT huntworkrichardhc atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT dahoralindsayc atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT nyanhetetinashe atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT duttasheetij atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT willereeceulrike atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT jongerterik atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT ewerkatiej atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT hilladrianvs atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT jincelina atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT hilljennifer atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT pollardandrewj atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT muniralams atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT tomarasgeorgiad atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT dennisonsmoses atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT likan toolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT doddsmichael toolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT sprengrachell toolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT abrahamilite toolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT huntworkrichardhc toolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT dahoralindsayc toolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT nyanhetetinashe toolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT duttasheetij toolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT willereeceulrike toolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT jongerterik toolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT ewerkatiej toolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT hilladrianvs toolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT jincelina toolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT hilljennifer toolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT pollardandrewj toolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT muniralams toolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT tomarasgeorgiad toolforevaluatingheterogeneityinavidityofpolyclonalantibodies
AT dennisonsmoses toolforevaluatingheterogeneityinavidityofpolyclonalantibodies